Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Borg

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Pathologie-Biologie|July 21, 2004
[hScrib: a potential novel tumor suppressor]J-P Borg
Current Topics in Microbiology and Immunology|December 24, 1997
Function of PTB domainsJ P Borg, B Margolis
Bulletin Du Cancer|April 1, 1997
[Receptors for factors of the VEGF (Vascular Endothelial Growth Family)]E Fournier, D Birnbaum, J P Borg
The Journal of Biological Chemistry|December 5, 1998
Interaction of cytosolic adaptor proteins with neuronal apolipoprotein E receptors and the amyloid precursor proteinM Trommsdorff, J P Borg, B Margolis, et al.
Molecular and Cellular Biology|November 1, 1996
The phosphotyrosine interaction domains of X11 and FE65 bind to distinct sites on the YENPTY motif of amyloid precursor proteinJ P Borg, J Ooi, E Levy, et al.
Kidney International|December 28, 1999
The function of PTB domain proteinsB Margolis, J P Borg, S Straight, et al.
Oncogene|September 7, 1995
Mutation at tyrosine residue 1337 abrogates ligand-dependent transforming capacity of the FLT4 receptorE Fournier, P Dubreuil, D Birnbaum, et al.
Arthritis and Rheumatism|July 1, 1981
Enhanced neutral protease activity in proliferating rheumatoid synovial cellsV B Hatcher, J P Borg, M A Levitt, et al.
The Journal of Biological Chemistry|September 30, 2000
Modulation of amyloid precursor protein metabolism by X11alpha /Mint-1. A deletion analysis of protein-protein interaction domainsH T Mueller, J P Borg, B Margolis, et al.
Molecular and Cellular Biology|November 2, 2001
8p12 stem cell myeloproliferative disorder: the FOP-fibroblast growth factor receptor 1 fusion protein of the t(6;8) translocation induces cell survival mediated by mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt/mTOR pathwaysG Guasch, V Ollendorff, J P Borg, et al.
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Pathologie-Biologie|July 21, 2004
[hScrib: a potential novel tumor suppressor]J-P Borg
Current Topics in Microbiology and Immunology|December 24, 1997
Function of PTB domainsJ P Borg, B Margolis
Bulletin Du Cancer|April 1, 1997
[Receptors for factors of the VEGF (Vascular Endothelial Growth Family)]E Fournier, D Birnbaum, J P Borg
The Journal of Biological Chemistry|December 5, 1998
Interaction of cytosolic adaptor proteins with neuronal apolipoprotein E receptors and the amyloid precursor proteinM Trommsdorff, J P Borg, B Margolis, et al.
Molecular and Cellular Biology|November 1, 1996
The phosphotyrosine interaction domains of X11 and FE65 bind to distinct sites on the YENPTY motif of amyloid precursor proteinJ P Borg, J Ooi, E Levy, et al.
Kidney International|December 28, 1999
The function of PTB domain proteinsB Margolis, J P Borg, S Straight, et al.
Oncogene|September 7, 1995
Mutation at tyrosine residue 1337 abrogates ligand-dependent transforming capacity of the FLT4 receptorE Fournier, P Dubreuil, D Birnbaum, et al.
Arthritis and Rheumatism|July 1, 1981
Enhanced neutral protease activity in proliferating rheumatoid synovial cellsV B Hatcher, J P Borg, M A Levitt, et al.
The Journal of Biological Chemistry|September 30, 2000
Modulation of amyloid precursor protein metabolism by X11alpha /Mint-1. A deletion analysis of protein-protein interaction domainsH T Mueller, J P Borg, B Margolis, et al.
Molecular and Cellular Biology|November 2, 2001
8p12 stem cell myeloproliferative disorder: the FOP-fibroblast growth factor receptor 1 fusion protein of the t(6;8) translocation induces cell survival mediated by mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt/mTOR pathwaysG Guasch, V Ollendorff, J P Borg, et al.
Pageof 4